Frontlight ResearchEarly access
Trial site
Velocity Nova Sp. z o.o.
- 12running trials
- 1closed trial
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Heart failure3 trials
- Psoriasis3 trials
- Atrial fibrillation2 trials
- Chronic kidney disease1 trial
- Hidradenitis suppurativa1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Vitiligo1 trial
- Phase
- Phase 313 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Not yet recruiting2 trials
- Completed1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Alumis Inc1 trial
- Amgen Inc.1 trial
- and 4 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Obesity2 recruiting
- Atrial fibrillation1 recruiting
- Hidradenitis suppurativa1 recruiting
- Psoriasis1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
- Vitiligo1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026